FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Floxin In Dextrose 5% In Plastic Container, and what generic alternatives are available?
Floxin In Dextrose 5% In Plastic Container is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Floxin In Dextrose 5% In Plastic Container
A generic version of FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as ofloxacin by CHARTWELL RX on September 2nd, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 8 |
DailyMed Link: | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Montefiore Medical Center | Phase 3 |
University of California, San Francisco | Phase 4 |
Winston Chamberlain, MD, PhD | Phase 4 |
See all FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-004 | Mar 31, 1992 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-005 | Mar 31, 1992 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-004 | Mar 31, 1992 | 4,382,892 | ⤷ Subscribe |
Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-005 | Mar 31, 1992 | 4,382,892 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
See the table below for patents covering FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 8301977 | ⤷ Subscribe | |
Spain | 505116 | ⤷ Subscribe | |
Bosnia and Herzegovina | 97190 | ⤷ Subscribe | |
Croatia | P930087 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0413455 | 98C0040 | Belgium | ⤷ Subscribe | PRODUCT NAME: ALATROFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/060/001 19980327; FIRST REGISTRATION: CH 54484 19980327 |
1429780 | 13C0012 | France | ⤷ Subscribe | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
0206283 | SPC/GB97/085 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606 |
1429780 | 122012000070 | Germany | ⤷ Subscribe | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |